首页 | 本学科首页   官方微博 | 高级检索  
     

心肌梗死患者抗醛固酮治疗心功能变化的临床研究
引用本文:刘长福,杨庭树,徐勇,智光,韩宝石. 心肌梗死患者抗醛固酮治疗心功能变化的临床研究[J]. 心肺血管病杂志, 2010, 0(Z1): 68-68
作者姓名:刘长福  杨庭树  徐勇  智光  韩宝石
作者单位:解放军总医院心内科;
摘    要:Objective:To evaluate the effect of diabetes on outcome of sirolimus-eluting stent.Methods:From December 2002 to May 2005,262 diabetes and 262 non-diabetics treated with sirolimus-eluting stents were studied.The follow-up angiography was performed in 8-month.Major adverse cardiac events(MACE)defined as death,myocardial infarction,or target lesion revascularization and follow-up angiography were analyzed.Results:Successful rate of stent implantation was 100%.There was no death during the procedure,hospitalization,and follow-up period.Acute myocardial infarction occurred in 1 diabetic at 2 days after PCI,and in 2 non-diabetics at follow-up period.Angiographic follow up at 8 months showed that absolute late lumen loss was 0.06 vs 0.04mm(P>0.05),relative late lumen loss was 2.32% vs 1.63%,and TLR rate was 12.60% vs 9.92% in diabetic group and non-diabetic group respectively.Logistic regression analysis showed that reference vessel lumen and relative late lumen loss were significantly associated with restenosis.Conclusion:Cypher stent implantation in diabetes is safe and effective,while relative late lumen loss may be related to restenosis.In a word,diabetes with small vessel may be considered to be risk factor for restenosis after Cypher stents implantation.

关 键 词:心肌梗死  醛固酮  安体舒通  治疗前后  患者  二尖瓣环  心功能变化  临床研究  统计学意义  平均值

Analysis of the effect of sirolimus-eluting stent on diabetes
WU Xiaofan,LIU Hong,SONG Xiantao. Analysis of the effect of sirolimus-eluting stent on diabetes[J]. Journal of Cardiovascular and Pulmonary Diseases, 2010, 0(Z1): 68-68
Authors:WU Xiaofan  LIU Hong  SONG Xiantao
Affiliation:,GE Changjiang,CHEN Xin,JIN Zening,ZHOU Yuan,MENG Kang,TIAN Rui,LV Shuzheng Department of Cardiology,Capital Medical University affiliated Beijing Anzhen Hospital,Beijing 100029,China
Abstract:Objective:To evaluate the effect of diabetes on outcome of sirolimus-eluting stent.Methods:From December 2002 to May 2005,262 diabetes and 262 non-diabetics treated with sirolimus-eluting stents were studied.The follow-up angiography was performed in 8-month.Major adverse cardiac events(MACE)defined as death,myocardial infarction,or target lesion revascularization and follow-up angiography were analyzed.Results:Successful rate of stent implantation was 100%.There was no death during the procedure,hospitalization,and follow-up period.Acute myocardial infarction occurred in 1 diabetic at 2 days after PCI,and in 2 non-diabetics at follow-up period.Angiographic follow up at 8 months showed that absolute late lumen loss was 0.06 vs 0.04mm(P>0.05),relative late lumen loss was 2.32% vs 1.63%,and TLR rate was 12.60% vs 9.92% in diabetic group and non-diabetic group respectively.Logistic regression analysis showed that reference vessel lumen and relative late lumen loss were significantly associated with restenosis.Conclusion:Cypher stent implantation in diabetes is safe and effective,while relative late lumen loss may be related to restenosis.In a word,diabetes with small vessel may be considered to be risk factor for restenosis after Cypher stents implantation.
Keywords:
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号